Skip to main content

Scienture Holdings, Inc.

For the period ended Dec 31, 2025. Filed Mar 30, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 30, 2026

SCNX$3.20+2.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SCIENTURE HOLDINGS, INC.
By:/s/ Dr. Narasimhan Mani
Dr. Narasimhan Mani
Co-Chief Executive Officer and President
By:/s/ Dr. Shankar Hariharan
Dr. Shankar Hariharan
Co-Chief Executive Officer and Executive Chairman

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this registration statement has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Dr. Narasimhan ManiCo-Chief Executive Officer and PresidentMarch 30, 2026
Dr. Narasimhan Mani(Co-Principal Executive Officer)
/s/ Dr. Shankar HariharanCo-Chief Executive Officer and Executive ChairmanMarch 30, 2026
Dr. Shankar Hariharan(Co-Principal Executive Officer)
/s/ Eric SherbChief Financial OfficerMarch 30, 2026
Eric Sherb(Principal Financial and Accounting Officer)
/s/ Donald G. FellDirectorMarch 30, 2026
Donald G. Fell
/s/ Mayur DoshiDirectorMarch 30, 2026
Mayur Doshi
/s/ Subbarao JayanthiDirectorMarch 30, 2026
Subbarao Jayanthi
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.